Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes.

Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes. Diabetes Care. 2013 Dec; 36(12):3953-60.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Breast Neoplasms
California
Colorectal Neoplasms
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Female
Follow-Up Studies
Humans
Hypoglycemic Agents
Incidence
Insulin Glargine
Insulin, Long-Acting
Male
Middle Aged
Proportional Hazards Models
Prostatic Neoplasms
Retrospective Studies
Risk
Risk Assessment
Time Factors
Young Adult

authors with profiles

Assiamira Ferrara, MD, PhD
Stephen K. Van Den Eeden, PhD
Charles P. Quesenberry, PhD
Laurel A. Habel, PhD
Ousseny Zerbo, PhD